Aloxi 250 micrograms solution for injection
Aloxi is indicated for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy and the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy, in adults and paediatric patients 1 month of age and older.
The active ingredient contained in this product is Palonosetron (as Hydrochloride).
Aloxi is currently available in the following presentation:
- 250mg/5ml solution for injection available in packs of 1 vial
This product is distributed in the Republic of Ireland by Fannin Ltd in partnership with Sinclair IS Pharma (This link will take you to a non-Fannin Ltd. website. Fannin Ltd. does not recommend, endorse or accept liability for sites controlled by third-parties).
For a copy of the SPC please click here.
Method of Sale: POM
EU Number: EU 1/04/306/001
MAH Holder: Helsinn Birex Pharmaceuticals Ltd. Damastown Mulhuddart Dublin 15 Ireland
Additional information available on request.
Date of preparation: July 2018